Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.7%

4 terminated/withdrawn out of 552 trials

Success Rate

95.5%

+8.9% vs industry average

Late-Stage Pipeline

11%

62 trials in Phase 3/4

Results Transparency

6%

5 of 85 completed trials have results

Key Signals

158 recruiting5 with results

Enrollment Performance

Analytics

N/A
192(55.5%)
Phase 2
73(21.1%)
Phase 4
39(11.3%)
Phase 3
23(6.6%)
Phase 1
12(3.5%)
Early Phase 1
7(2.0%)
346Total
N/A(192)
Phase 2(73)
Phase 4(39)
Phase 3(23)
+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (552)

Showing 20 of 552 trials
NCT07856355Phase 4Not Yet Recruiting

Tobramycin Nebulization to Prevent Multidrug-Resistant Ventilator-Associated Pneumonia

Role: collaborator

NCT07675889Not ApplicableRecruiting

Intraoperative Longitude-Latitude-Depth Localization Versus Preoperative CT-Guided Percutaneous Lung Puncture Localization for 0.8-2 cm Peripheral Pulmonary Nodules

Role: lead

NCT07757906Not ApplicableActive Not Recruiting

Clinical Application of an AI-based Dissection Trajectory Prediction System (ADTPS) in Endoscopic Submucosal Dissection

Role: lead

NCT05901389Not ApplicableCompleted

Continuous Lidocaine Infusion Via Closed Chest Drainage Tube for Pain Control After Thoracoscopic Partial Lung Resection

Role: lead

NCT07831551Not ApplicableNot Yet Recruiting

EECP for Erectile Dysfunction in Elderly Hypertensive Patients

Role: lead

NCT07744659Not ApplicableRecruiting

Spinal Cord Stimulation for Poststroke Spasticity

Role: collaborator

NCT07832188Not ApplicableRecruiting

A Study on the Efficacy of Dual-Carrier-Frequency Transcranial Alternating Current Stimulation Modulating the Hippocampus for the Treatment of Chronic Non-Specific Low Back Pain

Role: lead

NCT07383909Not ApplicableRecruiting

Remote Ischemic Preconditioning for Aute Type A Aortic Dissection Surgery

Role: collaborator

NCT07690306Enrolling By Invitation

Development and Validation of a Non-Invasive AI Diagnostic Model for Prostate Cancer Using Multiparametric MRI and PSMA PET/CT

Role: collaborator

NCT06730373Phase 2Recruiting

First-line Treatment With RC48 Plus Sintilimab and S-1 in Advanced Gastric Cancer (RCTS2)

Role: lead

NCT05339529Not ApplicableCompleted

Protective Effect of Thymosin α1 Against Negative Immune Dysregulation and Organ Dysfunction After Acute Aortic Dissection Surgery (PANDA II)

Role: collaborator

NCT06358209Not ApplicableRecruiting

Safety and Efficacy of Ventricular Irrigation for Ventriculitis

Role: collaborator

NCT07809542Recruiting

Brain Network Characteristics of Pain Patients Based on Magnetoencephalography

Role: lead

NCT07208864Not ApplicableRecruiting

Efficacy of an AI System in Training Endoscopists to Assess Gastric Intestinal Metaplasia Via the EGGIM Score

Role: lead

NCT05812287Recruiting

Exploring the Difference Between Gastric Cardia Cancer and Non-cardia Gastric Cancer Based on Multiomics

Role: lead

NCT07543263Recruiting

An Artificial Intelligence System for Multimodal, Multi-class Diagnosis of Pancreatic Cystic Lesions Based on Endoscopic Ultrasonography

Role: lead

NCT07089199Phase 2Recruiting

Tislelizumab Combined With Anlotinib and Nab-paclitaxel in III Resectable Non-small Cell Lung Cancer : A Prospective, Single-Arm, Phase II Study

Role: lead

NCT06702891Recruiting

Integrative Analysis of Exosome-Mediated Single-Cell Transcriptomics and Proteomics in Gastric Cardia Cancer

Role: lead

NCT07495137Not ApplicableNot Yet Recruiting

The Improvement Effect of Real-time Artificial Intelligence Assisted Identification of Bleeding Points on Hemostasis Efficiency in Endoscopic Submucosal Dissection

Role: lead

NCT07185373Phase 2Recruiting

Orelabrutinib Combined With Teniposide, Rituximab and Methotrexate for Newly Diagnosed PCNSL

Role: collaborator